Literature-Related Discovery (LRD): Potential treatments for Parkinson's Disease

Abstract Literature-Related Discovery (LRD) is the linking of two or more literature concepts that have heretofore not been linked (i.e., disjoint), in order to produce novel, interesting, plausible, and intelligible knowledge (i.e., potential discovery). The open discovery systems (ODS) component of LRD starts with a problem to be solved, and generates solutions to that problem through potential discovery. We have been using ODS LRD to identify potential treatments or preventative actions for challenging medical problems, among myriad other applications. The previous two papers in this Special Issue describe the application of ODS LRD to Raynaud's Phenomenon (RP) and to cataracts. Parkinson's Disease (PD) is a progressive neurodegenerative disorder, affecting approximately 1% of individuals older than 60 years, and is characterized by resting tremor, rigidity, bradykinesia, and postural instability. We selected the subject of PD because of its global prevalence, and its apparent intractability to all treatments except for palliative remediation mainly through drugs or surgery. Our first goal was to identify non-drug non-surgical treatments that would 1) prevent the occurrence, or 2) reduce the progression rate, or 3) stop the progression, or 4) maybe even reverse the progression, of PD. Our second goal was to demonstrate that we could again solve an ODS problem (using LRD) with no prior knowledge of any results or prior work (unlike the case of the RP problem). As in the ‘cataract’ example, we used the MeSH taxonomy of MEDLINE to restrict potential discoveries to selected semantic classes, and to identify potential discoveries efficiently. Our third goal was to generate large amounts of potential discovery in more than an order of magnitude less time than required for the RP study. The discovery generation methodology has been developed to the point where ODS LRD problems can be solved with no results or knowledge of any prior work.

[1]  Ha Won Kim,et al.  Protective Effect of Sulforaphane against Dopaminergic Cell Death , 2007, Journal of Pharmacology and Experimental Therapeutics.

[2]  A. Fallarero,et al.  Effects of aqueous extracts of Halimeda incrassata (Ellis) Lamouroux and Bryothamnion triquetrum (S.G.Gmelim) Howe on hydrogen peroxide and methyl mercury-induced oxidative stress in GT1-7 mouse hypothalamic immortalized cells. , 2003, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[3]  T. Hemnani,et al.  Experimental excitotoxicity provokes oxidative damage in mice brain and attenuation by extract of Asparagus racemosus , 2004, Journal of Neural Transmission.

[4]  Jeong Gu Lee,et al.  Antioxidative properties of brown algae polyphenolics and their perspectives as chemopreventive agents against vascular risk factors , 2003, Archives of pharmacal research.

[5]  Abdelouahed Khalil,et al.  Marrubium vulgare extract inhibits human-LDL oxidation and enhances HDL-mediated cholesterol efflux in THP-1 macrophage. , 2006, Life sciences.

[6]  X-M Li,et al.  Protective effect of Lycium barbarum polysaccharides on streptozotocin-induced oxidative stress in rats. , 2007, International journal of biological macromolecules.

[7]  Hans Wohlmuth,et al.  Antioxidant capacity of 55 medicinal herbs traditionally used to treat the urinary system: a comparison using a sequential three-solvent extraction process. , 2007, Journal of alternative and complementary medicine.

[8]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Water purification , 2008 .

[9]  D Sivanesan,et al.  Preventive role of Gynandropsis gynandra L., against aflatoxin B1 induced lipid peroxidation and antioxidant defense mechanism in rat. , 2007, Indian journal of experimental biology.

[10]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Potential treatments for cataracts , 2008 .

[11]  N. Tomita,et al.  Isohumulones Derived from Hops Ameliorate Renal Injury via an Anti-Oxidative Effect in Dahl Salt-Sensitive Rats , 2007, Hypertension Research.

[12]  J. Rocha,et al.  Commonly used tropical medicinal plants exhibit distinct in vitro antioxidant activities against hepatotoxins in rat liver. , 2007, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[13]  Bernd Stratmann,et al.  Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. , 2007, The American journal of clinical nutrition.

[14]  Ronald N. Kostoff,et al.  Literature-Related Discovery (LRD): Introduction and background , 2008 .

[15]  L. Dragsted,et al.  Ex-vivo and in vitro protective effects of kolaviron against oxygen-derived radical-induced DNA damage and oxidative stress in human lymphocytes and rat liver cells , 2004, Cell Biology and Toxicology.

[16]  Roger A. Barker,et al.  Lewy bodies in Parkinson's disease: Protectors or perpetrators? , 2005, Experimental Neurology.

[17]  Qin Feng,et al.  Intervention effects of Jianpi Liqi Huoxue Decoction (健脾理气活血汤) on lipid peroxidative liver injury induced by alcohol , 2006, Chinese journal of integrative medicine.

[18]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Methodology , 2008 .

[19]  J Takeuchi,et al.  [Details and indications of pallidotomy and thalamotomy for Parkinson's disease]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[20]  J. Takahashi,et al.  Stem cell therapy for Parkinson’s disease , 2007, Ernst Schering Research Foundation workshop.

[21]  Dong-Hyun Kim,et al.  Flavonoids from the flower ofRhododendron yedoense var.Poukhanense and their antioxidant activities , 2007 .

[22]  Ming Zhan,et al.  Mitochondrial UCP4 mediates an adaptive shift in energy metabolism and increases the resistance of neurons to metabolic and oxidative stress , 2007, NeuroMolecular Medicine.

[23]  D. Sulzer,et al.  Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease , 2007, Trends in Neurosciences.

[24]  S. F. Arruda,et al.  Carotenoids from malanga (Xanthosoma sagittifolium) leaves protect cells against oxidative stress in rats. , 2005, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[25]  Ronald N. Kostoff,et al.  Literature-related discovery (LRD): Potential treatments for Raynaud's Phenomenon☆ , 2008 .

[26]  T. Landauer,et al.  Indexing by Latent Semantic Analysis , 1990 .

[27]  K Indira Priyadarsini,et al.  Inhibition of peroxynitrite-mediated reactions by vanillin. , 2004, Journal of agricultural and food chemistry.

[28]  U. Kang,et al.  Potential of gene therapy for Parkinson's disease: neurobiologic issues and new developments in gene transfer methodologies. , 1998, Movement disorders : official journal of the Movement Disorder Society.

[29]  R. Hauser,et al.  Advances in the Pharmacologic Management of Early Parkinson Disease , 2007, The neurologist.

[30]  Barbara Shukitt-Hale,et al.  Dietary supplementation with blueberry extract improves survival of transplanted dopamine neurons , 2006, Nutritional neuroscience.

[31]  H U Nwanjo,et al.  Anti-lipid peroxidative activity of Gongronema latifolium in streptozotocin-induced diabetic rats. , 2010, Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria.

[32]  László Vécsei,et al.  [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease]. , 2007, Ideggyogyaszati szemle.

[33]  Debasis Bagchi,et al.  Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats , 2007, Molecular and Cellular Biochemistry.

[34]  S. Mandel,et al.  Green tea polyphenol (−)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal , 2009, Neurotoxicity Research.

[35]  C. Gerfen,et al.  D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Animal Model of Parkinson’s Disease , 2003, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[36]  Jin Won Hyun,et al.  Cytoprotective effects of KIOM-79 on streptozotocin induced cell damage by inhibiting ERK and AP-1. , 2007, Biological & pharmaceutical bulletin.

[37]  P. Calabresi,et al.  A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine–acetylcholine synaptic balance , 2006, The Lancet Neurology.

[38]  Jean Féger,et al.  Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe , 2003, Journal of neurochemistry.

[39]  Pin-Der Duh,et al.  Comparison of protective effects between cultured Cordyceps militaris and natural Cordyceps sinensis against oxidative damage. , 2006, Journal of agricultural and food chemistry.

[40]  A. Lozano,et al.  Deep brain stimulation for the treatment of Parkinson's disease. , 2006, Journal of neural transmission. Supplementum.

[41]  J. Volkmann DEEP BRAIN STIMULATION II Deep Brain Stimulation for the Treatment of Parkinson’s Disease , 2004 .

[42]  Michael J Thun,et al.  Consumption of dairy products and risk of Parkinson's disease. , 2007, American journal of epidemiology.

[43]  P. Fraker,et al.  The many roles of apoptosis in immunity as modified by aging and nutritional status. , 2004, The journal of nutrition, health & aging.